Cohen Joshua Binsider trades

In SEC Form 4 filings, Cohen Joshua B is listed as Co-Chief Executive Officer of Amylyx Pharmaceuticals, Inc. (AMLX). In the last 90 days, Cohen Joshua B sold $980.5K of Amylyx Pharmaceuticals, Inc. (AMLX) on the open market and bought none.

Companies and roles

Company	Role	Transactions	Last filed
AMLXAmylyx Pharmaceuticals, Inc.	Co-Chief Executive Officer	2	Sep 14

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-14

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
AMLXAmylyx Pharmaceuticals, Inc.	Sep 10	Sep 14	S	29,545	$32.16	Sale −$950,040	3,614,042	No	Form 4
AMLXAmylyx Pharmaceuticals, Inc.	Sep 10	Sep 14	S	919	$33.15	Sale −$30,464	3,613,123	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.